We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.
The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ...
Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.
Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.
At Orphalan we identify, develop and provide access to innovative treatments for patients with rare diseases.
Orphalan UK Ltd. has taken steps to understand all potential modern slavery risks related to its business, in accordance with Section 54 of the UK Modern Slavery Act 2015.
We are committed to preventing slavery and human trafficking, both in our own corporate activities and our supply chain. We take measures to ensure that all of our contractors, suppliers and business partners comply with the same high standards.
Click here to view the PDF.
Orphalan UK is committed to achieving Net Zero emissions by 2045. Click here to access the report.
© 2025 Orphalan SA. All rights reserved | Website services by FDM Digital | JB EU-ORPH-CORP-24008 - June 2024
